TEVA יחס מהיר Teva Pharmaceutical Industries Limited

Teva Pharmaceutical Industries (TEVA) maintains a global network of plants that guarantees the production of critical medications, and the quick ratio on GURU.Markets reflects this stability through the value 0.69, which captures the metric level. The holding company is currently betting on innovative drugs and debt reduction, leveraging its Pivot to Growth strategy. This development is based on organic renewal and targeted alliances without new acquisitions.

Investors are evaluating Teva Pharmaceutical Industries (TEVA) through the lens of its ability to service significant debt amid generic price volatility. This metric measures the company's capacity to settle short-term obligations using only cash and accounts receivable, excluding inventory. An analysis of the quick ratio allows for a real-time assessment of the business's actual solvency. Growth in this indicator confirms the success of the strategy to reduce debt load and stabilize cash flows.